Zealand Pharma A/S

ZLDPF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$404,233$7,573,699-$335,343-$291,034
Dep. & Amort.$7,223$6,211$5,959$6,275
Deferred Tax$0$0$0$0
Stock-Based Comp.$30,810$31,853$22,866$25,046
Change in WC-$164,598-$93,531-$179,298$134,134
Other Non-Cash$461,214$1,001,085-$14,975-$54,898
Operating Cash Flow-$69,584$8,519,317-$500,791-$180,477
Investing Activities
PP&E Inv.-$571-$6,423-$6,454-$1,176
Net Acquisitions$0$0$0$0
Inv. Purchases-$542,744-$6,160,082-$2,563,132-$1,796,439
Inv. Sales/Matur.$409,184$4,592,562$3,126,508$1,950,178
Other Inv. Act.$0-$310-$2,304-$1,817
Investing Cash Flow-$134,131-$1,574,253$554,618$150,746
Financing Activities
Debt Repay.$0-$4,428-$4,336-$4,586
Stock Issued$298$27,088$3,545$81
Stock Repurch.-$11,723-$332,408$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$849$0$0-$100
Financing Cash Flow-$12,274-$309,748-$791-$4,605
Forex Effect$11,341-$167,420-$2,918$3,621
Net Chg. in Cash-$204,648$6,467,896$50,118-$30,715
Supplemental Information
Beg. Cash$1,141,169$776,151$726,033$511,018
End Cash$936,521$7,244,047$776,151$480,303
Free Cash Flow-$70,155$8,512,584-$509,549-$183,470